Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00050
F. Çetin, H. Emiroğlu, Saliha Calisir, S. Türkoğlu
How to cite this article: Cetin FH, Emiroglu HH, Calisir S, Turkoglu S. Digital rectal stimulation associated with psychiatric disorders as a rare reason of solitary rectal ulcer in children and adolescents: a case series. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:352-354. Digital rectal stimulation associated with psychiatric disorders as a rare reason of solitary rectal ulcer in children and adolescents: a case series
{"title":"Digital rectal stimulation associated with psychiatric disorders as a rare reason of solitary rectal ulcer in children and adolescents: a case series study","authors":"F. Çetin, H. Emiroğlu, Saliha Calisir, S. Türkoğlu","doi":"10.14744/dajpns.2019.00050","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00050","url":null,"abstract":"How to cite this article: Cetin FH, Emiroglu HH, Calisir S, Turkoglu S. Digital rectal stimulation associated with psychiatric disorders as a rare reason of solitary rectal ulcer in children and adolescents: a case series. Dusunen Adam The Journal of Psychiatry and Neurological Sciences 2019;32:352-354. Digital rectal stimulation associated with psychiatric disorders as a rare reason of solitary rectal ulcer in children and adolescents: a case series","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78150225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00006
B. Yucens
{"title":"The association between hope, anxiety, depression, coping strategies and perceived social support in patients with chronic kidney disease","authors":"B. Yucens","doi":"10.14744/dajpns.2019.00006","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00006","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81006419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00043
Faruk Kılıç
Correspondence: Faruk Kilic, Suleyman Demirel University, Faculty of Medicine, Department of Psychiatry, Isparta Turkey Phone: +90 246 211 93 35 E-mail: drfarukk33@hotmail.com Received: August 15, 2019; Revised: September 23, 2019; Accepted: October 18, 2019 ABSTRACT Objective: Schizophrenia is a significant burden for the patient and causes great costs for society. The etiology of schizophrenia, which is known to be a neurodevelopmental disorder, has not been fully elucidated. Differences in prenatal gonadal hormones have been suggested to play a role in the pathogenesis of schizophrenia. An easy way to evaluate a biomarker that gives insight about prenatal androgen is the second to fourth digit ratio (2D:4D) of the hand. In this study, we aimed to compare the 2D:4D ratio of schizophrenia patients to healthy controls and to investigate the relationship with positive and negative symptoms. Method: Seventy-six patients with schizophrenia and 67 healthy controls were included in the study. Finger lengths were measured from the proximal finger crease to the tip using a digital vernier caliper with a precision of 0.01 mm. The Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS) were used to evaluate the symptoms of schizophrenia. Results: While the left 2D:4D ratio of the patients with schizophrenia was not different from the controls’, the right 2D:4D ratio was significantly lower. The correlation between finger lengths and the SAPS and SANS scores by gender showed a negative correlation of the left and right 2D:4D ratio with the SANS scores in female patients, while the SANS scores were found to be positively correlated with the right 2D:4D ratio in men. Conclusion: The findings of our study support the view that the right 2D:4D ratio may be an indicator for schizophrenia.
{"title":"Investigation of second to fourth finger length ratio (2D:4D) in schizophrenia patients","authors":"Faruk Kılıç","doi":"10.14744/dajpns.2019.00043","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00043","url":null,"abstract":"Correspondence: Faruk Kilic, Suleyman Demirel University, Faculty of Medicine, Department of Psychiatry, Isparta Turkey Phone: +90 246 211 93 35 E-mail: drfarukk33@hotmail.com Received: August 15, 2019; Revised: September 23, 2019; Accepted: October 18, 2019 ABSTRACT Objective: Schizophrenia is a significant burden for the patient and causes great costs for society. The etiology of schizophrenia, which is known to be a neurodevelopmental disorder, has not been fully elucidated. Differences in prenatal gonadal hormones have been suggested to play a role in the pathogenesis of schizophrenia. An easy way to evaluate a biomarker that gives insight about prenatal androgen is the second to fourth digit ratio (2D:4D) of the hand. In this study, we aimed to compare the 2D:4D ratio of schizophrenia patients to healthy controls and to investigate the relationship with positive and negative symptoms. Method: Seventy-six patients with schizophrenia and 67 healthy controls were included in the study. Finger lengths were measured from the proximal finger crease to the tip using a digital vernier caliper with a precision of 0.01 mm. The Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS) were used to evaluate the symptoms of schizophrenia. Results: While the left 2D:4D ratio of the patients with schizophrenia was not different from the controls’, the right 2D:4D ratio was significantly lower. The correlation between finger lengths and the SAPS and SANS scores by gender showed a negative correlation of the left and right 2D:4D ratio with the SANS scores in female patients, while the SANS scores were found to be positively correlated with the right 2D:4D ratio in men. Conclusion: The findings of our study support the view that the right 2D:4D ratio may be an indicator for schizophrenia.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76192254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00010
A. E. Altınöz, Duriye Gizem Tosun Dilci, Ferdi Köşger, Altan Eşsizoğlu
Suicide among inpatients can be devastating for other patients and hospital staff. Studies show that cases of inpatient suicides in general hospitals receive less attention than inpatient suicides in psychiatric hospitals. Studies on cases of inpatient suicide in general hospitals are usually in the form of case reports or case series, and potential suicide risk factors are unknown. Many significant differences are reported between inpatient suicides in general hospitals and inpatient suicides in psychiatry clinics. Here we report two cases of completed suicide after jumping from a height while receiving inpatient treatment at a University Hospital. As serious physical illnesses are frequently accompanied by psychiatric disorders that increase suicide risk, measures should be taken to prevent inpatient suicides in hospitals admitting patients with physical illnesses. Hospitals should keep regular records about inpatients who attempt or commit suicide during their treatment in the hospital or during treatment breaks, because this would provide valuable data to examine and prevent cases of inpatient suicide.
{"title":"Suicide by jumping from a height in a university hospital: two cases","authors":"A. E. Altınöz, Duriye Gizem Tosun Dilci, Ferdi Köşger, Altan Eşsizoğlu","doi":"10.14744/DAJPNS.2019.00010","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00010","url":null,"abstract":"Suicide among inpatients can be devastating for other patients and hospital staff. Studies show that cases of inpatient suicides in general hospitals receive less attention than inpatient suicides in psychiatric hospitals. Studies on cases of inpatient suicide in general hospitals are usually in the form of case reports or case series, and potential suicide risk factors are unknown. Many significant differences are reported between inpatient suicides in general hospitals and inpatient suicides in psychiatry clinics. Here we report two cases of completed suicide after jumping from a height while receiving inpatient treatment at a University Hospital. As serious physical illnesses are frequently accompanied by psychiatric disorders that increase suicide risk, measures should be taken to prevent inpatient suicides in hospitals admitting patients with physical illnesses. Hospitals should keep regular records about inpatients who attempt or commit suicide during their treatment in the hospital or during treatment breaks, because this would provide valuable data to examine and prevent cases of inpatient suicide.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83675636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00007
M. Yıldırım
Objective: Depressive symptoms are frequently observed in patients with stroke. In this study, we investigated the prevalence of depression and the factors affecting depression in patients with chronic stroke. Method: The study included 90 patients having had sustained a stroke attack at least 6 months previously. The demographic characteristics, time since stroke, hemiplegic side, etiology of stroke, stroke-related risk factors, complications and accompanying neurological disorders, drug use, and the presence of additional diseases were questioned. Depressive symptoms were assessed by using the Beck Depression Scale (BDS). The patients were divided into two groups according to the BDS score: group 1 included those with depression (BDS score ≥17), and group 2 included those without depression (BDS score
{"title":"Post stroke depression and related factors","authors":"M. Yıldırım","doi":"10.14744/dajpns.2019.00007","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00007","url":null,"abstract":"Objective: Depressive symptoms are frequently observed in patients with stroke. In this study, we investigated the prevalence of depression and the factors affecting depression in patients with chronic stroke. Method: The study included 90 patients having had sustained a stroke attack at least 6 months previously. The demographic characteristics, time since stroke, hemiplegic side, etiology of stroke, stroke-related risk factors, complications and accompanying neurological disorders, drug use, and the presence of additional diseases were questioned. Depressive symptoms were assessed by using the Beck Depression Scale (BDS). The patients were divided into two groups according to the BDS score: group 1 included those with depression (BDS score ≥17), and group 2 included those without depression (BDS score","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88728235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00002
M. Atagun
{"title":"Intrinsic oscillations of auditory networks in schizophrenia and bipolar disorder","authors":"M. Atagun","doi":"10.14744/dajpns.2019.00002","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00002","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89005771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00049
emine sevinç
{"title":"The Turkish validity and reliability study of the body esteem scale","authors":"emine sevinç","doi":"10.14744/dajpns.2019.00049","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00049","url":null,"abstract":"","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78879570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00015
H. Taş, Ozlem Ozusta
Correspondence: Halil İbrahim Tas, Canakkale Onsekiz Mart University, Faculty of Medicine, Department of Psychiatry, Canakkale Turkey Phone: +90 286 218 00 18 20 60 E-mail: tashalilibrahim@gmail.com Received: October 23, 2018; Revised: December 19, 2018; Accepted: March 13, 2019 ABSTRACT Objective: According to ICD-10, the diagnosis of unspecified mood disorder (UMD), coded ‘F39,’ is used when there is insufficient or contradictory information about the patient and the symptoms of mood disorder are not sufficient to diagnose a specific mood disorder. Information about the frequency, diagnostic validity and continuity of this diagnosis is unsatisfactory. Therefore, we aimed to evaluate the prevalence and diagnostic continuity of this diagnosis among individuals diagnosed with UMD in our outpatient clinic. Method: Included in the study were patients who presented to the psychiatry outpatient unit for the first time between January 2011 and December 2017, were diagnosed with mood disorder code ‘F39’ at the first admission, and presented at least three times in different periods (n=48). Outpatient unit records were evaluated retrospectively and the data were analyzed with SPSS version 19.0. Results: The mean follow-up period of 48 patients included in the study was 14.4±13.9 months. The final diagnoses of the patients after follow-up were UMD (42%), depressive disorder (25%), bipolar disorder (17%), and anxiety disorder (10%). It was found that the duration of the follow-up for individuals diagnosed with UMD was significantly shorter than for those with a different diagnosis. No significant difference was found between final diagnoses in terms of age, gender, level of education, and marital status. Conclusion: UMD has less diagnostic stability than other mood disorders. Therefore, longer follow-up durations are needed in patients with UMD, and it is crucial to reconsider the diagnosis during follow-up. Further studies with larger samples are needed to elucidate the stability of UMD.
{"title":"Evaluation of the diagnostic continuity of unspecified mood disorder","authors":"H. Taş, Ozlem Ozusta","doi":"10.14744/DAJPNS.2019.00015","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00015","url":null,"abstract":"Correspondence: Halil İbrahim Tas, Canakkale Onsekiz Mart University, Faculty of Medicine, Department of Psychiatry, Canakkale Turkey Phone: +90 286 218 00 18 20 60 E-mail: tashalilibrahim@gmail.com Received: October 23, 2018; Revised: December 19, 2018; Accepted: March 13, 2019 ABSTRACT Objective: According to ICD-10, the diagnosis of unspecified mood disorder (UMD), coded ‘F39,’ is used when there is insufficient or contradictory information about the patient and the symptoms of mood disorder are not sufficient to diagnose a specific mood disorder. Information about the frequency, diagnostic validity and continuity of this diagnosis is unsatisfactory. Therefore, we aimed to evaluate the prevalence and diagnostic continuity of this diagnosis among individuals diagnosed with UMD in our outpatient clinic. Method: Included in the study were patients who presented to the psychiatry outpatient unit for the first time between January 2011 and December 2017, were diagnosed with mood disorder code ‘F39’ at the first admission, and presented at least three times in different periods (n=48). Outpatient unit records were evaluated retrospectively and the data were analyzed with SPSS version 19.0. Results: The mean follow-up period of 48 patients included in the study was 14.4±13.9 months. The final diagnoses of the patients after follow-up were UMD (42%), depressive disorder (25%), bipolar disorder (17%), and anxiety disorder (10%). It was found that the duration of the follow-up for individuals diagnosed with UMD was significantly shorter than for those with a different diagnosis. No significant difference was found between final diagnoses in terms of age, gender, level of education, and marital status. Conclusion: UMD has less diagnostic stability than other mood disorders. Therefore, longer follow-up durations are needed in patients with UMD, and it is crucial to reconsider the diagnosis during follow-up. Further studies with larger samples are needed to elucidate the stability of UMD.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87141260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/dajpns.2019.00041
C. Evren
Cannabidiol (CBD) is a phytocannabinoid derived from the Cannabis sativa plant, just l ike tetrahydrocannabinol (THC), but in contrast with the latter it shows no psychoactive effect. Unlike THC, CBD does not activate the reward system; however, it effects the opioid, serotonin, and cannabinoid receptor systems. Therefore, it is thought to be promising for the treatment of drug addiction. In particular, it acts as a non-competitive antagonist of CB1 receptor within the cannabinoid system (1). However, CBD has been shown not to be acting directly on the CB1 receptor. Most studies reported that it has no effect on the CB1 receptor at all, while some studies showed weak agonistic or weak antagonistic effects. CBD also has a low affinity for another cannabinoid receptor, the CB2 receptor (2). CBD can be converted into THC in some animal species and in laboratory settings, but this conversion does not happen in the human body (2,3). Because of its action on various receptors, cannabidiol’s effect is being investigated in many physical or psychiatric diseases. Clinical studies for the treatment of epilepsy are ongoing and positive results have been reported. In some preclinical studies, although not mainly in epilepsy, CBD has been shown to have neuroprotective, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor features (2). The therapeutic use of CBD has also been investigated in substance use disorders. Several preclinical studies have reported that CBD may have a therapeutic effect on opioid, cocaine, and psychostimulant addiction. Some studies have also obtained data suggesting that CBD may be beneficial in cannabis and tobacco addiction in humans (4). Substance use causes dysregulation in the mesolimbic circuit. CBD alleviates this dysregulation when administered regularly. Because of this feature, CBD was considered to be beneficial in substance use disorder. It is considered that its efficacy may depend on the dose and on whether it is administered before or in combination with the substance used (1). CBD is also thought to blunt the reward-facilitating effect of substance use through 5HT1A receptor agonism, which is effective in reducing stress and anxiety in the mesolimbic system. This suggestion is based on selective serotonin reuptake inhibitors and other antidepressants reducing substance use by alleviating mood symptoms. ABSTRACT
{"title":"The good face of Cannabis sativa: Cannabidiol","authors":"C. Evren","doi":"10.14744/dajpns.2019.00041","DOIUrl":"https://doi.org/10.14744/dajpns.2019.00041","url":null,"abstract":"Cannabidiol (CBD) is a phytocannabinoid derived from the Cannabis sativa plant, just l ike tetrahydrocannabinol (THC), but in contrast with the latter it shows no psychoactive effect. Unlike THC, CBD does not activate the reward system; however, it effects the opioid, serotonin, and cannabinoid receptor systems. Therefore, it is thought to be promising for the treatment of drug addiction. In particular, it acts as a non-competitive antagonist of CB1 receptor within the cannabinoid system (1). However, CBD has been shown not to be acting directly on the CB1 receptor. Most studies reported that it has no effect on the CB1 receptor at all, while some studies showed weak agonistic or weak antagonistic effects. CBD also has a low affinity for another cannabinoid receptor, the CB2 receptor (2). CBD can be converted into THC in some animal species and in laboratory settings, but this conversion does not happen in the human body (2,3). Because of its action on various receptors, cannabidiol’s effect is being investigated in many physical or psychiatric diseases. Clinical studies for the treatment of epilepsy are ongoing and positive results have been reported. In some preclinical studies, although not mainly in epilepsy, CBD has been shown to have neuroprotective, anxiolytic, antipsychotic, analgesic, anti-inflammatory, anti-asthmatic, and antitumor features (2). The therapeutic use of CBD has also been investigated in substance use disorders. Several preclinical studies have reported that CBD may have a therapeutic effect on opioid, cocaine, and psychostimulant addiction. Some studies have also obtained data suggesting that CBD may be beneficial in cannabis and tobacco addiction in humans (4). Substance use causes dysregulation in the mesolimbic circuit. CBD alleviates this dysregulation when administered regularly. Because of this feature, CBD was considered to be beneficial in substance use disorder. It is considered that its efficacy may depend on the dose and on whether it is administered before or in combination with the substance used (1). CBD is also thought to blunt the reward-facilitating effect of substance use through 5HT1A receptor agonism, which is effective in reducing stress and anxiety in the mesolimbic system. This suggestion is based on selective serotonin reuptake inhibitors and other antidepressants reducing substance use by alleviating mood symptoms. ABSTRACT","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90578920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.14744/DAJPNS.2019.00016
Yasemin Kayha, Nermin Taskale
Correspondence: Yasemin Kahya, Social Sciences University of Ankara, Faculty of Humanities and Social Sciences, Department of Psychology, Hukumet Meydani, No. 2, 06030 Ulus, Altindag, Ankara Turkey Phone: +90 312 596 44 44 E-mail: yaseminoruclular@gmail.com Received: November 21, 2018; Revised: December 11, 2018; Accepted: March 11, 2019 ABSTRACT Objective: The first purpose of the current study was to examine the typology of intimate partner violence experiences of community sample women via two-step cluster analysis. The second purpose was to investigate how difficulties in emotion regulation, separation anxiety, and impulsivity would predict the clusters of intimate partner violence including both victim and perpetrator roles. Method: A total of 253 female participants who were married/in a relationship currently or during the past year were included in the statistical analyses. Participants completed online a Demographic Information Form, the Revised Conflict Tactics Scale-2, the Difficulties in Emotion Regulation Scale, the Adult Separation Anxiety Questionnaire, and the Short Form of the Barratt Impulsiveness Scale. Results: The two-step clustering method indicated that violence experiences of women in the community who were mostly victims of psychological violence fell into two different clusters of low and moderate violence experiences. The total scores of difficulties in emotion regulation and separation anxiety symptoms increased the likelihood of being in the moderate violence cluster while the total score of impulsivity was not related to violence clusters. Conclusion: Violence experience of women in the community is a complex phenomenon that simultaneously includes victim and perpetrator roles and is experienced at different levels. Findings underlined the role of women’s affect-regulation difficulties and their feelings towards significant others and intimate relationships in their violence experiences.
{"title":"The Difficulties in Emotion Regulation, Separation Anxiety and Impulsivity as Predictors of Women’s Intimate Partner Violence Experiences","authors":"Yasemin Kayha, Nermin Taskale","doi":"10.14744/DAJPNS.2019.00016","DOIUrl":"https://doi.org/10.14744/DAJPNS.2019.00016","url":null,"abstract":"Correspondence: Yasemin Kahya, Social Sciences University of Ankara, Faculty of Humanities and Social Sciences, Department of Psychology, Hukumet Meydani, No. 2, 06030 Ulus, Altindag, Ankara Turkey Phone: +90 312 596 44 44 E-mail: yaseminoruclular@gmail.com Received: November 21, 2018; Revised: December 11, 2018; Accepted: March 11, 2019 ABSTRACT Objective: The first purpose of the current study was to examine the typology of intimate partner violence experiences of community sample women via two-step cluster analysis. The second purpose was to investigate how difficulties in emotion regulation, separation anxiety, and impulsivity would predict the clusters of intimate partner violence including both victim and perpetrator roles. Method: A total of 253 female participants who were married/in a relationship currently or during the past year were included in the statistical analyses. Participants completed online a Demographic Information Form, the Revised Conflict Tactics Scale-2, the Difficulties in Emotion Regulation Scale, the Adult Separation Anxiety Questionnaire, and the Short Form of the Barratt Impulsiveness Scale. Results: The two-step clustering method indicated that violence experiences of women in the community who were mostly victims of psychological violence fell into two different clusters of low and moderate violence experiences. The total scores of difficulties in emotion regulation and separation anxiety symptoms increased the likelihood of being in the moderate violence cluster while the total score of impulsivity was not related to violence clusters. Conclusion: Violence experience of women in the community is a complex phenomenon that simultaneously includes victim and perpetrator roles and is experienced at different levels. Findings underlined the role of women’s affect-regulation difficulties and their feelings towards significant others and intimate relationships in their violence experiences.","PeriodicalId":11480,"journal":{"name":"Dusunen Adam: The Journal of Psychiatry and Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82233128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：